Genpharmasec Reports Strong Q3 FY24-25 Results with Improved Sales and Profitability
Genpharmasec has announced its financial results for Q3 FY24-25, showcasing a significant increase in net sales to Rs 8.48 crore, alongside an operating profit of Rs 0.73 crore. The company also reported its highest operating profit margin in five quarters, reflecting improved operational efficiency and profitability.
Genpharmasec, a microcap company in the trading industry, has recently reported its financial results for the quarter ending December 2024. The results indicate a notable performance for Q3 FY24-25, with a revision in its score reflecting the positive developments observed over the past three months.The company's net sales reached Rs 8.48 crore, marking a growth of 22.0% compared to the average net sales of Rs 6.95 crore from the previous four quarters. This upward trend in sales is complemented by an operating profit (PBDIT) of Rs 0.73 crore, the highest recorded in the last five quarters, suggesting an enhancement in operational efficiency.
Additionally, Genpharmasec reported an operating profit margin of 8.61%, also the highest in the last five quarters, indicating improved efficiency. The profit before tax (PBT) stood at Rs 0.48 crore, while the profit after tax (PAT) reached Rs 0.78 crore, both reflecting positive trends in profitability. Furthermore, earnings per share (EPS) increased to Rs 0.01, showcasing the company's ability to generate higher earnings for its shareholders.
For more insights, Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
